Local and systemic antitumor effect of intratumoral and peritumoral IL-12 electrogene therapy on murine sarcoma

Cancer Biology and Therapy

Volumn 8, Issue 22, 2009, Pages 2114-2122

  Pavlin, Darja ^a   Cemazar, Maja ^b   Kamensek, Urska ^b   Tozon, Natasa ^a   Pogacnik, Azra ^a   Sersa, Gregor ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Electrogene therapy; Electroporation; IL 12; Sarcoma; Skin; Tumor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; RECOMBINANT DNA;

A J MOUSE; ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; CANCER TRANSPLANTATION; COMPARATIVE STUDY; ELECTROPORATION; EVALUATION; FIBROSARCOMA; GENE THERAPY; GENE VECTOR; GENETICS; GERMFREE ANIMAL; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; INTRALESIONAL DRUG ADMINISTRATION; MALE; METHODOLOGY; MOUSE; MULTIPLE CANCER; PATHOLOGY; PLASMID; RANDOMIZATION; RECURRENT DISEASE; SOFT TISSUE TUMOR; SUBCUTANEOUS TISSUE;

ANIMALS; DNA, RECOMBINANT; ELECTROPORATION; FIBROSARCOMA; GENE THERAPY; GENETIC VECTORS; IMMUNOLOGIC MEMORY; INJECTIONS, INTRADERMAL; INJECTIONS, INTRALESIONAL; INTERFERON-GAMMA; INTERLEUKIN-12; MALE; MICE; MICE, INBRED A; NEOPLASM TRANSPLANTATION; NEOPLASMS, MULTIPLE PRIMARY; PLASMIDS; RANDOM ALLOCATION; RECURRENCE; SOFT TISSUE NEOPLASMS; SPECIFIC PATHOGEN-FREE ORGANISMS; SUBCUTANEOUS TISSUE;

EID: 76949104598     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.22.9734     Document Type: Article

References (47)

1. Pisters PWT, O'Sullivan B, Demetri GD. Sarcomas of Nonosseous tissues. In: Kufe DW, Bast RC, Hait WM, Hong WK, Pollock RE, Weichselbaum RR, et al. eds. Cancer Medicine. 6th ed. Hamilton:BC Decker Inc 2006; 1348-422.
2. Kane JM, Finley JW, Driscoll D, Kraybill WG, Gibbs JF. The treatment and outcome of patients with soft tissue sarcomas and synchronous metastases. Sarcoma 2002; 6:69-73. (Pubitemid 35239297)
3. Singh RP, Grimer RJ, Bhujel N, Carter SR, Tillman RM, Abudu A. Adult head and neck soft tissue sarcomas: treatment and outcome. Sarcoma 2008; 2008:654987.
4. Gambotto A, Tüting T, McVey DL, Kovesdi I, Tahara H, Lotze MT, et al. Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12. Cancer Gene Ther 1999; 6:45-53. (Pubitemid 129667758)
5. Gao JQ, Sugita T, Kanagawa N, Iida K, Motomura Y, Mizuguchi H, et al. A single intratumoral injection of fiber-mutant adenoviral vector encoding IL-12 induces remarkable anti-tumor and anti-metastatic activity in mice with Meth-A fibrosarcoma. Biochem Biophys Res Comm 2005; 328:1043-50. (Pubitemid 40238740)
6. Siddiqui F, Li C-Y, LaRue SM, Poulson JM, Avery PR, Pruitt AF, et al. A phase I trial of hyperthermia-induced interleukin-12 gene therapy in spontaneously arising feline soft tissue sarcomas. Mol Cancer Ther 2007; 6:380-9.
7. Jia S-F, Duan X, Worth LL, Guan H, Kleinerman ES. Intratumor murine interleukin-12 gene therapy suppressed the growth of local and distant Ewing's sarcoma. Cancer Gene Ther 2006; 13:948-57. (Pubitemid 44373795)
8. Worth LL, Jia S-F, Zhou Z, Chen L, Kleinerman ES. Intranasal therapy with adenoviral vector containing the murine interleukin-12 gene eradicates osteosarcoma lung metastases. Clin Cancer Res 2000; 6:3713-8.
9. Itokawa Y, Mazda O, Ueda Y, Kishida T, Asada H, Cui FD, et al. Interleukin-12 genetic administration suppressed metastatic liver tumor unsusceptible to CTL. Biochem Biophys Res Comm 2004; 314:1072-9. (Pubitemid 38142392)
10. Morini M, Albini A, Lorusso G, Moelling K, Lu B, Cilli M, et al. Prevention of angiogenesis by naked DNA IL-12 gene transfer: angioprevention by immunogene therapy. Gene Ther 2004; 11:284-91. (Pubitemid 38220080)
11. Ajiki T, Murakami T, Kobayashi Y, Hakamata Y, Wang J, Inoue S, et al. Long-lastning gene espression by particle-mediated intramuscular transfection modified with bupivacaine: combinatorial gene therapy with IL-12 and IL18 cDNA against rat sarcoma at a distant site. Cancer Gene Ther 2003; 10:318-29. (Pubitemid 36423114)
12. Jia S-F, Worth LL, Densmore CL, Xu B, Zhou Z, Kleinerman ES. Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using nonviral polyethylenimine vector. Cancer Gene Ther 2002; 9:260-6. (Pubitemid 34205500)
13. Jia S-F, Worth LL, Densmore CL, Xu B, Duan X, Kleinerman ES. Aerosol gene therapy with PEI: IL-12 eradicates osteosarcoma lung metastases. Clin Cancer Res 2003; 9:3462-8. (Pubitemid 37082745)
14. Duan X, Jia S-F, Koshkina N, Kleinerman ES. Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases. Cancer 2006; 106:1382-8. (Pubitemid 43363918)
15. Aihara H, Miyaziki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16:867-70. (Pubitemid 28405859)
16. Rols MP, Delteile C, Golizo M, Dumond P, Cros S, Teissie J. In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 1998; 16:168-71. (Pubitemid 28078505)
17. Cemazar M, Sersa G, Wilson J, Tozer GM, Hart SL, Grosel A, et al. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes and integrin-targeted vector. Cancer Gene Ther 2002; 9:399-406. (Pubitemid 34289459)
18. Mir LM, Bureau MF, Gehl J, Rangara R, Rouy D, Caillaud JM, et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 1999; 96:4262-7. (Pubitemid 29190324)
19. Prud'homme GJ, Glinka Y, Khan AS, Draghia-Akli R. Electroporation- enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases. Curr Gene Ther 2006; 6:243-73.
20. Cemazar M, Sersa G. Electrotransfer of therapeutic molecules into tissues. Curr Opin Mol Ther 2007; 9:554-62. (Pubitemid 350179095)
21. Kamensek U, Sersa G. Targeted gene therapy in radiotherapy. Radiol Oncol 2008; 42:115-35.
22. Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008; 26:5896-903.
23. Kishida T, Asada H, Satoh E, Tanaka S, Shinya M, Hirai H, et al. In vivo electroporation-mediated transfer of IL-12 and IL18 genes induces significant antitumor effects against melanoma in mice. Gene Ther 2001; 8:1234-40. (Pubitemid 32780811)
24. Lohr F, Lo DY, Zaharoff DA, Hu K, Zhang X, Li Y, et al. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation. Cancer Res 2001; 61:3281-4. (Pubitemid 32695013)
25. Lucas ML, Heller L, Coppola D, Heller R. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. Mol Ther 2002; 5:668-75. (Pubitemid 34624563)
26. Lucas ML, Heller R. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma. DNA Cell Biol 2003; 22:755-63. (Pubitemid 38032998)
27. Lee SC, Wu CJ, Wu PY, Huang YL, Wu CW, Tao MH. Inhibition of established subcutaneous and metastatic murine tumors by intramuscular electroporation of the interleukin-12 gene. J Biomed Sci 2003; 10:73-86.
28. Heller L, Merkler K, Westover J, Cruz Y, Coppola D, Benson K, et al. Evaluation of toxicity following electrically mediated interleukin-12 gene delivery in a B16 mouse melanoma model. Clin Cancer Res 2006; 12:3177-83. (Pubitemid 43837367)
29. Hanna E, Zhang X, Woodlis J, Breau R, Suen J, Li S. Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site. Cancer Gene Ther 2001; 8:151-7. (Pubitemid 32322254)
30. Li S, Zhang X, Xia X. Regression of tumor growth and induction of long-term antitumor memory by IL-12 electro-gene therapy. J Nat Cancer Inst 2002; 94:762-8. (Pubitemid 34567961)
31. Li S, Zhang L, Torrero M, Cannon M, Barret R. Administration route- and immune cell activationdependant tumor eradication by IL-12 electrotransfer. Mol Ther 2005; 12:942-9. (Pubitemid 41614490)
32. Torrero M, Li S. Treatment of SCCVII tumors with systemic chemotherapy and interleukin-12 gene therapy combination. Methods Mol Biol 2008; 432:339-49.
33. Goto T, Nishi T, Kobayashi O, Tamura T, Dev SB, Takeshima H, et al. Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmid is highly effective against murine carcinomas in vivo. Mol Ther 2004; 10:929-37. (Pubitemid 39419918)
34. Tamura T, Nishi T, Goto T, Takeshima H, Ushio Y, Sakata T. Combination of IL-12 and IL-18 of electrogene therapy synergistically inhibits tumor growth. Anticancer Res 2003; 23:1173-9. (Pubitemid 36754075)
35. Tamura T, Nishi T, Goto T, Takeshima H, Dev SB, Ushio Y, et al. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer. Hum Gene Ther 2001; 12:1265-76. (Pubitemid 32681841)
36. Harada N, Shimada M, Okano S, Suehiro T, Soejima Y, Tomita Y, et al. IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice. J Immunol 2004; 173:6635-44. (Pubitemid 39541047)
37. Yamashita Y, Shimada M, Hasegawa H, Minagawa R, Rikimaru T, Hamatsu T, et al. Electroporationmediated IL-12 gene therapy for hepatocellular carcinoma in the mice model. Cancer Res 2001; 61:1005-12. (Pubitemid 32174418)
38. Wells DJ. Gene therapy progress and prospects: electroporation and other physical methods. Gene Ther 2004; 11:1363-9. (Pubitemid 39263889)
39. Zhag L, Nolan E, Kreitschitz S, Rabussay DP. Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation. Biochim Biophys Acta 2002; 1572:1-9. (Pubitemid 35229983)
40. Pavselj N, Préat V. DNA electrotransfer into the skin using a combination of one high- and one low-voltage pulse. J Cont Rel 2005; 106:407-15. (Pubitemid 41187449)
41. Pavselj N, Préat V, Miklavcic D. A numerical model of skin electropermeabilization based on in vivo experiments. Ann Biomed Eng 2007; 35:2138-44. (Pubitemid 350165300)
42. Heller R, Schultz J, Lucas ML, Jaroszeski MJ, Heller LC, Gilbert RA, et al. Intradermal delivery of interleukin-12 plasmid DNA by in vivo electroporation. DNA Cell Biol 2001; 20:21-6. (Pubitemid 32108776)
43. Hanna E, Zhang X, Woodlis J, Breau R, Suen J, Li S. Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site. Cancer Gene Ther 2001; 8:151-7. (Pubitemid 32322254)
44. Zhu S, Li S. Systemic IL-12 gene therapy for treating malignancy via intramuscular electroporation. Methods Mol Biol 2008; 423:327-37.
45. Li S, Zhalng L, Torrero M, Cannon M, Barret R. Administration route- and immune cell activationdependent tumor eradication by IL-12 electrotransfer. Mol Ther 2005; 12:942-9. (Pubitemid 41614490)
46. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990; 249:912-5.
47. Heller LC, Coppola D. Electrically mediated delivery of vector plasmid DNA elicits an antitumor effect. Gene Ther 2002; 9:1321-5.